Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9036582 | 0.98 | AGTR1 (0.41) | AGTR1AGTR2 | |
| SCHEMBL9035001 | 0.94 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL9035592 | 0.94 | AGTR1 (0.46) | AGTR1AGTR2 | |
| SCHEMBL9035710 | 0.94 | AGTR1 (0.44) | AGTR1AGTR2 | |
| SCHEMBL9036536 | 0.93 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL9036490 | 0.93 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL9036270 | 0.91 | AGTR1 (0.38) | AGTR1AGTR2 | |
| SCHEMBL9035648 | 0.91 | AGTR1 (0.45) | AGTR1AGTR2 | |
| SCHEMBL9035422 | 0.91 | AGTR1 (0.43) | AGTR1AGTR2 | |
| SCHEMBL9554445 | 0.91 | AGTR1 (0.37) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0555331-B1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | SEARLE & CO (US) | 1996-04-24 | — | — | EP | claimed |
| EP-0555331-B1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | SEARLE & CO (US) | 1996-04-24 | — | — | EP | disclosed |
| US-5238952-A | Treating glaucoma disorders | G. D. SEARLE & CO. (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1992007834-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |
| US-5087634-A | N-substituted imidazol-2-one compounds for treatment of circulatory disorders | G. D. SEARLE & CO. (US) | 1992-02-11 | — | — | US | disclosed |